Literature DB >> 27738881

Prognostic value of the frequency of vascular invasion in stage I non-small cell lung cancer.

Satoshi Okada1, Shinjiro Mizuguchi2, Nobuhiro Izumi1, Hiroaki Komatsu1, Michihito Toda1, Kantaro Hara1, Takahiro Okuno3, Toshihiko Shibata1, Hideki Wanibuchi3, Noritoshi Nishiyama1.   

Abstract

OBJECTIVES: There is no standard pathological method for determining vessel invasion in lung cancer. Herein, we examine whether vessel invasion can be accurately assessed using hematoxylin-eosin staining alone, and investigate the prognostic impact of the presence and frequency of vessel invasion in lung cancer.
METHODS: Vessel invasion was assessed by hematoxylin-eosin, Victoria blue, and D2-40 in 251 completely resected stage I non-small cell lung cancer patients. Vessel invasion was classified into 3 grades according to the number of invaded vessels.
RESULTS: Using hematoxylin-eosin and Victoria blue, vascular invasion was detected in 27 (10.8 %) and 75 (29.9 %) of patients, respectively. Lymphatic permeation was detected in 126 (50.2 %) and 70 (27.9 %) of patients using hematoxylin-eosin and D2-40 staining. Hematoxylin-eosin staining did not accurately detect a high frequency of vessel invasion; only 5 and 21.7 % of high-frequency vascular invasion and lymphatic permeation cases diagnosed with Victoria blue and D2-40 were detected. Multivariate analysis based on elastic stain and immunostaining indicated that plural invasion, a high frequency of vascular invasion (hazard ratio 4.00), and a high frequency of lymphatic permeation (hazard ratio 2.30) were independent predictors of cancer recurrence within 3 years. Likewise, an age ≥70 years, male, and a high frequency of vascular invasion (hazard ratio 3.41) were independent predictors of overall survival.
CONCLUSIONS: Vascular invasion should be confirmed by elastic stains, and the frequency, not but the presence, of vascular invasion is a powerful independent prognostic factor in completely resected stage I non-small cell lung cancer patients.

Entities:  

Keywords:  Early stage; Lung cancer; Prognosis; Vascular invasion

Mesh:

Year:  2016        PMID: 27738881     DOI: 10.1007/s11748-016-0720-6

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  25 in total

Review 1.  The new World Health Organization classification of lung tumours.

Authors:  E Brambilla; W D Travis; T V Colby; B Corrin; Y Shimosato
Journal:  Eur Respir J       Date:  2001-12       Impact factor: 16.671

2.  Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.

Authors:  D H Harpole; J E Herndon; W G Young; W G Wolfe; D C Sabiston
Journal:  Cancer       Date:  1995-09-01       Impact factor: 6.860

3.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

4.  Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer.

Authors:  Kentaroh Miyoshi; Shigeharu Moriyama; Tadayoshi Kunitomo; Sugato Nawa
Journal:  J Thorac Cardiovasc Surg       Date:  2008-09-14       Impact factor: 5.209

5.  Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.

Authors:  Jian-guo Sun; Yan Wang; Zheng-tang Chen; Wen-lei Zhuo; Bo Zhu; Rong-xia Liao; Shao-xiang Zhang
Journal:  J Exp Clin Cancer Res       Date:  2009-02-16

6.  Lymphatic invasion predicts survival in patients with early node-negative non-small cell lung cancer.

Authors:  Michael F Nentwich; Benjamin A Bohn; Faik G Uzunoglu; Matthias Reeh; Alexander Quaas; Tobias J Grob; Daniel Perez; Asad Kutup; Maximilian Bockhorn; Jakob R Izbicki; Yogesh K Vashist
Journal:  J Thorac Cardiovasc Surg       Date:  2013-06-15       Impact factor: 5.209

Review 7.  Lymphovascular invasion as a prognostic indicator in stage I non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Nathan M Mollberg; Carrie Bennette; Eric Howell; Leah Backhus; Beth Devine; Mark K Ferguson
Journal:  Ann Thorac Surg       Date:  2014-01-11       Impact factor: 4.330

8.  Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer.

Authors:  Shinjiro Mizuguchi; Noritoshi Nishiyama; Takashi Iwata; Tatsuya Nishida; Nobuhiro Izumi; Takuma Tsukioka; Kiyotoshi Inoue; Takahiro Uenishi; Kenichi Wakasa; Shigefumi Suehiro
Journal:  Lung Cancer       Date:  2007-08-13       Impact factor: 5.705

9.  Accuracy and prognostic impact of a vessel invasion grading system for stage IA non-small cell lung cancer.

Authors:  Satoshi Hashizume; Takeshi Nagayasu; Tomayoshi Hayashi; Shigekazu Hidaka; Tomoshi Tsuchiya; Tsutomu Tagawa; Naoya Yamasaki; Katsuro Furukawa; Keitaro Matsumoto; Takuro Miyazaki
Journal:  Lung Cancer       Date:  2009-01-21       Impact factor: 5.705

Review 10.  Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Jun Wang; Jianpeng Chen; Xi Chen; Baocheng Wang; Kainan Li; Jingwang Bi
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

View more
  5 in total

1.  Risk analyses of N2 lymph-node metastases in patients with T1 non-small cell lung cancer: a multi-center real-world observational study in China.

Authors:  Bing Chen; Wenjie Xia; Zhongqiu Wang; Heng Zhao; Xiaofei Li; Lunxu Liu; Yang Liu; Jian Hu; Xiangning Fu; Yin Li; Yijun Xu; Deruo Liu; Haiying Yang; Lin Xu; Feng Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2019-08-19       Impact factor: 4.553

2.  Preoperative bronchoscopic cancer confirmation does not increase risk of recurrence in stage1A non-small cell lung cancer.

Authors:  Jiro Abe; Toshimasa Okazaki; Naohiko Kikuchi; Satomi Takahashi; Akira Sakurada; Yoshinori Okada
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-03-21

3.  Intensity of SLX predicts distance of tumor spread through alveolar spaces in stage I lung adenocarcinoma.

Authors:  Kantaro Hara; Shinjiro Mizuguchi; Satoshi Okada; Nobuhiro Izumi; Takuma Tsukioka; Hiroaki Komatsu; Masahiko Ohsawa; Mayumi Inaba; Toshihiko Shibata; Noritoshi Nishiyama
Journal:  Thorac Cancer       Date:  2019-02-28       Impact factor: 3.500

4.  Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB-IIA Lung Adenocarcinoma.

Authors:  Wenyu Zhai; Li Gong; Yuzhen Zheng; Qihang Yan; Renchun Lai; Dachuan Liang; Wingshing Wong; Shuqin Dai; Junye Wang
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

5.  [Prognostic Factors of N2 Stage Non-small Cell Lung Cancer after Surgery].

Authors:  Zhenyu Yang; Shiyou Wei; Liang Xia; Lunxu Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.